Payden & Rygel Annual Revenue, Competitors, Number of Employees and Funding
Estimated Revenue & Financials
- Payden & Rygel's estimated annual revenue is currently $39M per year.
- Payden & Rygel's estimated revenue per employee is $227,000
- Payden & Rygel has 172 Employees.
- Payden & Rygel grew their employee count by 6% last year.
- Payden & Rygel currently has 1 job openings.
Payden & Rygel Competitors
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Dowling & Yahnk...||N/A||35||N/A||N/A|
|Kayne Anderson ...||$71.5M||315||9%||N/A|
What Is Payden & Rygel?
Payden & Rygel is one of the largest independently-owned global investment management firms. We offer a full array of investment strategies and products, including equity, fixed-income and balanced portfolios as well as open-end mutual funds and offshore funds, to a varied client base around the world. While we have grown and expanded considerably since our inception, we remain committed to our mission of providing customized investment management services that focus on each client's specific needs and objectives.keywords:N/A
Number of Employees
Employee Growth %
|Justin Bullion||Managing Principal||Email Available|
|Earl Parker||Senior Vice President||Email Available|
|Diane Williams||Senior Vice President||Email Available|
|Kristin Ceva||Managing Principal||Email Available|
|Henry Lim||Vice President||Email Available|
|James Sarni||Managing Principal||Email Available|
|Adam Congdon||Portfolio Manager|
|Oscar Lopez||Vice President, Manager Network Administration||Email Available|
|Lisa Matiash||Associate Vice President||Email Available|
|Brad Boyd||Portfolio Manager - Core Bond/absolute Return, Senior Vice President||Email Available|
Payden & Rygel News
Payden & Rygel increased its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.6% in the 2nd quarter, according to the company in its ...
Payden & Rygel chief economist Jeffrey Cleveland on the U.S. economy and why investors shouldn't panic over the inverted yield curve last ...
Payden & Rygel lifted its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.6% in the second quarter, HoldingsChannel.com reports.